RET and lung carcinoma: Current guidelines consequently note that single gene testing for the presence of RET fusions is not recommended on a stand-alone basis in patients with advanced NSCLC, but suggest that RET analysis should form part of any large multigene panel test developed for patients with lung cancer (1).